Cogent Biosciences
COGT
#5783
Rank
NZ$1.53 B
Marketcap
$13.86
Share price
0.51%
Change (1 day)
51.95%
Change (1 year)

Cogent Biosciences (COGT) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.59 Billion

According to Cogent Biosciences's latest financial reports the company has NZ$0.59 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cogent Biosciences - Cash on Hand chart (from 2017 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.42 B2.89%
2022-12-31NZ$0.40 B26.97%
2021-12-31NZ$0.32 B-4.18%
2020-12-31NZ$0.33 B504.04%
2019-12-31NZ$55.56 M-52.57%
2018-12-31NZ$0.11 B103.15%
2017-12-31NZ$57.67 M-41.68%
2016-12-31NZ$98.9 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$28.96 M-95.12%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.71 B 21.13%๐Ÿ‡บ๐Ÿ‡ธ USA